Lv FF, Li MY, Qu W, Jiang ZS. Rivaroxaban for the treatment of heparin-induced thrombocytopenia with thrombosis in a patient undergoing artificial hip arthroplasty: A case report. World J Clin Cases 2023; 11(26): 6147-6153 [PMID: 37731576 DOI: 10.12998/wjcc.v11.i26.6147]
Corresponding Author of This Article
Zhao-Shun Jiang, Doctor, Professor, Department of Endocrinology, 960th Hospital of PLA, No. 25 Shifan Road, Tianqiao District, Jinan 250014, Shandong Province, China. jzs012@163.com
Research Domain of This Article
Substance Abuse
Article-Type of This Article
Case Report
Open-Access Policy of This Article
This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Share the Article
Lv FF, Li MY, Qu W, Jiang ZS. Rivaroxaban for the treatment of heparin-induced thrombocytopenia with thrombosis in a patient undergoing artificial hip arthroplasty: A case report. World J Clin Cases 2023; 11(26): 6147-6153 [PMID: 37731576 DOI: 10.12998/wjcc.v11.i26.6147]
World J Clin Cases. Sep 16, 2023; 11(26): 6147-6153 Published online Sep 16, 2023. doi: 10.12998/wjcc.v11.i26.6147
Rivaroxaban for the treatment of heparin-induced thrombocytopenia with thrombosis in a patient undergoing artificial hip arthroplasty: A case report
Fang-Fang Lv, Mei-Ye Li, Wei Qu, Zhao-Shun Jiang
Fang-Fang Lv, Mei-Ye Li, Wei Qu, Zhao-Shun Jiang, Department of Endocrinology, 960th Hospital of PLA, Jinan 250014, Shandong Province, China
Author contributions: Lv FF performed the data collection and the literature search and wrote the manuscript; Li MY reviewed the literature and edited the manuscript; Qu W and Jiang ZS contributed to the collection of data and guaranteed the integrity of the entire study; All authors read and approved the manuscript.
Informed consent statement: The patient provided informed written consent prior to publication.
Conflict-of-interest statement: All the authors report having no relevant conflicts of interest for this article.
CARE Checklist (2016) statement: The authors have read the CARE Checklist (2016), and the manuscript was prepared and revised according to the CARE Checklist (2016).
Open-Access: This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/
Corresponding author: Zhao-Shun Jiang, Doctor, Professor, Department of Endocrinology, 960th Hospital of PLA, No. 25 Shifan Road, Tianqiao District, Jinan 250014, Shandong Province, China. jzs012@163.com
Received: April 15, 2023 Peer-review started: April 15, 2023 First decision: July 7, 2023 Revised: July 13, 2023 Accepted: July 19, 2023 Article in press: July 19, 2023 Published online: September 16, 2023 Processing time: 146 Days and 4.8 Hours
Abstract
BACKGROUND
Anticoagulation treatment after lower limb surgery is one of the key methods to avoid thrombosis, and low-molecular-weight heparin is the treatment that is most frequently used in clinical practice. But one uncommon side effect of low-molecular-weight heparin is heparin-induced thrombocytopenia (HIT), which can develop into thrombosis if not caught early or managed incorrectly.
CASE SUMMARY
We present a case of a patient who underwent hip arthroplasty and experienced thrombocytopenia due to HIT on the 9th d following the application of low-molecular-weight heparin anticoagulation. We did not diagnose HIT in time and applied 1 unit of platelets to the patient, which led to thrombosis. Luckily, the patient recovered following effective and timely surgery and treatment with rivaroxaban.
CONCLUSION
Patients using low-molecular-weight heparin after lower limb surgery need to have their platelet counts regularly checked. If HIT develops, platelet treatment should be given with caution.
Core Tip: Anticoagulation treatment after lower limb surgery is one of the key methods to avoid thrombosis, and low-molecular-weight heparin is the treatment that is most frequently used in clinical practice. But one uncommon side effect of low-molecular-weight heparin is heparin-induced thrombocytopenia. If heparin-induced thrombocytopenia develops, platelet treatment should be given with caution.
